WAY-640509

CAS No. 851185-20-1

WAY-640509( —— )

Catalog No. M35313 CAS No. 851185-20-1

WAY-640509 is a glucocerebrosidase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 166 In Stock
5MG 255 In Stock
10MG 375 In Stock
25MG 562 In Stock
50MG 770 In Stock
100MG 1051 In Stock
200MG Get Quote In Stock
500MG 2111 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-640509
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-640509 is a glucocerebrosidase inhibitor.
  • Description
    Glucocerebrosidase-IN-2 is a inhibitor of glucokinase with AC50 value of 25.29 μM in N370S Tissue.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Glucokinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    851185-20-1
  • Formula Weight
    489.55
  • Molecular Formula
    C25H23N5O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(=O)(=O)(N1CCN(C=2C3=C(N=C(N2)C=4C=CC=NC4)C=CC=C3)CC1)C=5C=C6C(=CC5)OCCO6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Juan J Marugan, et al. Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity. J Med Chem. 2011, 54, 4.?
molnova catalog
related products
  • AZD-1656

    AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes.

  • AZ6102

    AZ6102 is a potent TNKS1/2 inhibitor that has 100-fold selectivity against other PARP family enzymes and shows IC50 of 5 nM for Wnt pathway inhibition in DLD-1 cells.

  • XL388

    XL388 is a highly effective, specifc, ATP-competitive inhibitor of mTOR ( IC50: 9.9 nM), 1000-fold selectivity than the closely related PI3K kinases.